Articulate Ventures

Iosif Gershteyn; CEO of ImmuVia, a BioTech Company Focusing on Hard-To-Treat Cancers

September 27, 2023 · The Vance Crowe Podcast

Iosif Gershteyn is the CEO of the company ImmuVia, a biotechnology company focused on oncological diseases, specifically hard-to-treat cancers. He discusses his work with his company ImmuVia, as well as his childhood experience in Russia & talks on many different angles of philosophy. essay mentioned: ImmuVia: For more philosophy: - Book a Legacy Interview | — A Legacy Interview is a two-hour recorded interview with you and a host that can be watched now and viewed in the future. It is a recording of what you experienced, the lessons you learned and the family values you want passed down. We will interview you or a loved one, capturing the sound of their voice, wisdom and a sense of who they are. These recorded conversations will be private, reserved only for the people that you want to share it with.

Bring this conversation to your organization. Vance Crowe speaks to conferences, boards, and leadership teams on trust, disagreement, and change.

Book Vance to speak

The Vance Crowe Podcast

Vance Crowe interviews people with an expertise you would want to know about, but might not think to ask.

Watch full interviews on YouTube: The Vance Crowe Podcast

Listen on Apple Podcasts or Spotify

Book Vance to speak: articulate.ventures/speaking

Record a private family interview: Legacy Interviews

← All episodes